Literature DB >> 29276182

Cytokine Profile of Leishmania Infantum Fucose-Mannose Ligand in Vaccinated Dogs in the Northwest of Iran.

Behnam Mohammadi-Ghalehbin1, Gholamreza Hatam, Bahador Sarkari, Mehdi Mohebali, Zabih Zarei, Shahab Bohlooli.   

Abstract

BACKGROUND: Canine visceral leishmaniasis (CVL) caused by Leishmania infantum is endemic in the northwest and south of Iran. An appropriate vaccine can help to prevent and control visceral leishmaniasis in both humans and animals. Few studies have confirmed that the fucose-mannose ligand (FML) antigen of Leishmania donovani produced protective immunity in dogs against CVL.
OBJECTIVE: To evaluate the immune responses of vaccinated dogs against FML antigen of L. infantum.
METHODS: We isolated the FML antigen from native L. infantum and vaccinated the dogs with FML-saponin in an endemic area of VL in Iran to evaluate the immune responses of vaccinated dogs against this antigen.
RESULTS: Our results indicated a significant increase in the expression of IFN-γ, IL-10 and IL-13, but not IL-12A, gene transcripts in PBMCs of FML-saponin vaccinated dogs in comparison with controls. Our findings showed a significant difference in the ratio of IFN-γ/IL-10 mRNA expression in FML-saponin vaccinated dogs in comparison with two control groups. Moreover, a significant level of anti-FML antibodies was detected in serum of vaccinated dogs.
CONCLUSION: These findings showed that FML-saponin stimulates both Th1 and Th2 immune responses with predominant Th1 and strong humoral immune responses to produce protective immunity against CVL.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29276182     DOI: IJIv14i4A4

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  3 in total

1.  Achievement amastigotes of Leishmania infantum and investigation of pathological changes in the tissues of infected golden hamsters.

Authors:  Sajad Rashidi; Kurosh Kalantar; Gholamreza Hatam
Journal:  J Parasit Dis       Date:  2018-03-05

2.  Sirolimus enhances the protection achieved by a DNA vaccine against Leishmania infantum.

Authors:  Alba Martínez-Flórez; Clara Martori; Paula L Monteagudo; Fernando Rodriguez; Jordi Alberola; Alhelí Rodríguez-Cortés
Journal:  Parasit Vectors       Date:  2020-06-09       Impact factor: 3.876

3.  Attenuated Leishmania major Induce a High Level of Protection against Leishmania infantum in BALB/c Mice.

Authors:  Shamsi Noorpisheh Ghadimi; Leila Homayoon; Reza Shahriarirad; Shakila Fatehpour; Mohammad Rastegarian; Bahador Sarkari
Journal:  Iran J Parasitol       Date:  2019 Apr-Jun       Impact factor: 1.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.